11:59 AM EDT, 07/23/2024 (MT Newswires) -- BeiGene ( BGNE ) said Tuesday it has opened its flagship biologics manufacturing facility and clinical research and development facility in Hopewell, New Jersey, located at the Princeton West Innovation Campus.

BeiGene's ( BGNE ) $800 million investment completes a three-year project to expand its US operations with a 42-acre facility featuring 400,000 square feet of biologic manufacturing space, supporting over 30 molecules and allowing for future growth.

Shares of BeiGene ( BGNE ) were down 3.1% in recent Tuesday trading.

Price: 156.00, Change: -4.94, Percent Change: -3.07